Drug Profile
Olamufloxacin
Alternative Names: HSR 903Latest Information Update: 29 Jan 2013
Price :
$50
*
At a glance
- Originator Abbott Japan
- Class Antibacterials; Fluoroquinolones; Small molecules
- Mechanism of Action DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 18 Feb 2008 Discontinued - Phase-III for Bacterial infections in Japan (PO)
- 18 Feb 2008 Discontinued - Preclinical for Bacterial infections in Japan (IV)
- 28 Feb 2003 Dainabot has merged with Hokuriku Seiyaku to form Abbott Japan